Could your own immune cells stop colon cancer returning?
NCT ID NCT05394714
First seen Jun 26, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This early-stage trial tests a new treatment called Magicell-NK for people with stage I or IIa colon cancer who have already had surgery to remove the tumor. The treatment uses a patient's own natural killer (NK) cells, which are grown and activated in a lab and then infused back into the body. The main goal is to check safety and find the best dose, with 18 participants receiving one of three dose levels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Magicell-NK (a patient's own natural killer cells grown and activated in a lab)
- What this could lead to
- If it works, this could point toward a treatment to prevent colon cancer from coming back after surgery without needing chemotherapy.
- What could go wrong
- This is a very early, small Phase 1 trial with only 18 people, focused on safety. It may not show any benefit, and side effects like infusion reactions or immune overactivation are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER STAGE I are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chang Gung Memorial Hospital, Linkou
RECRUITINGTaoyuan, 333, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.